Intrust Bank NA Has $336,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Intrust Bank NA lifted its stake in Colgate-Palmolive (NYSE:CL) by 16.6% during the fourth quarter, Holdings Channel.com reports. The fund owned 4,212 shares of the company’s stock after buying an additional 600 shares during the period. Intrust Bank NA’s holdings in Colgate-Palmolive were worth $336,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of CL. Morgan Stanley raised its holdings in shares of Colgate-Palmolive by 3.2% in the 3rd quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after purchasing an additional 514,559 shares during the period. Northern Trust Corp boosted its stake in shares of Colgate-Palmolive by 3.3% during the 3rd quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock worth $672,198,000 after acquiring an additional 305,862 shares during the period. American Century Companies Inc. increased its holdings in shares of Colgate-Palmolive by 2.0% during the 3rd quarter. American Century Companies Inc. now owns 6,590,405 shares of the company’s stock worth $468,644,000 after acquiring an additional 127,805 shares during the last quarter. FMR LLC increased its holdings in shares of Colgate-Palmolive by 27.3% during the 3rd quarter. FMR LLC now owns 5,597,742 shares of the company’s stock worth $398,055,000 after acquiring an additional 1,199,660 shares during the last quarter. Finally, Nordea Investment Management AB lifted its position in Colgate-Palmolive by 10.1% during the third quarter. Nordea Investment Management AB now owns 5,455,384 shares of the company’s stock worth $390,005,000 after acquiring an additional 500,916 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the stock. Citigroup boosted their price objective on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Evercore ISI increased their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. Morgan Stanley lifted their price objective on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a report on Monday, January 29th. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Finally, Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a research report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.44.

Colgate-Palmolive Trading Down 0.0 %

CL opened at $91.90 on Thursday. The company has a market cap of $75.40 billion, a P/E ratio of 29.08, a PEG ratio of 3.37 and a beta of 0.42. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 13.21. The company’s 50 day moving average is $88.08 and its 200-day moving average is $81.99. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $92.54.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the business posted $0.73 earnings per share. Equities research analysts predict that Colgate-Palmolive will post 3.52 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.18%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is currently 63.29%.

Insiders Place Their Bets

In related news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the sale, the insider now owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The disclosure for this sale can be found here. Insiders sold a total of 159,048 shares of company stock valued at $13,336,846 in the last 90 days. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.